Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD-2006-11-055723PMID 18024796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells.

  2007cited by this paper
• High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor.

  2007cited by this paper
• Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.

  2007cited by this paper
• Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

  2007cited by this paper
• Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

  2007cited by this paper
• Inhibition of heme oxygenase‐1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice

  2007cited by this paper
• KRAB Can Repress Lentivirus Proviral Transcription Independently of Integration Site*

  2006cited by this paper
• Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.

  2006cited by this paper
• Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

  2006cited by this paper
• BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.

  2006cited by this paper
• Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.

  2006cited by this paper
• Resistance to imatinib: mechanisms and management.

  2005cited by this paper
• Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

  2005cited by this paper
• Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.

  2005cited by this paper
• Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.

  2005cited by this paper
• Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.

  2005cited by this paper
• Heme oxygenase-1: from bench to bedside.

  2005cited by this paper
• Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia.

  2004cited by this paper
• Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment

  2004cited by this paper
• Four Years of Follow-Up of 1027 Patients with Late Chronic Phase (L-CP), Accelerated Phase (AP), or Blast Crisis (BC) Chronic Myeloid Leukemia (CML) Treated with Imatinib in Three Large Phase II Trials.

  2004cited by this paper
• Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis*

  2004cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only.

  2004cited by this paper
• Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

  2004cited by this paper
• Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin

  2004cited by this paper
• Rational siRNA design for RNA interference

  2004cited by this paper
• Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference

  2003cited by this paper
• In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor.

  2003cited by this paper
• Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour

  2003cited by this paper
• Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

  2003cited by this paper
• Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

  2003cited by this paper
• Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

  2002cited by this paper
• Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.

  2002cited by this paper
• Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance

  2002cited by this paper
• High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.

  2002cited by this paper
• Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis

  2002cited by this paper
• Heme oxygenase-1: the "emerging molecule" has arrived.

  2002cited by this paper
• Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective

  2002cited by this paper
• Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571).

  2002cited by this paper
• Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.

  2002cited by this paper
• Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis.

  2002cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

  2001cited by this paper
• Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms.

  2001cited by this paper
• Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines.

  2000cited by this paper
• The BCR/ABL Tyrosine Kinase Induces Production of Reactive Oxygen Species in Hematopoietic Cells*

  2000cited by this paper
• Heme oxygenase activity. Current methods and applications.

  2000cited by this paper
• Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL

  1998cited by this paper
• Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

  1997cited by this paper
• Transformation of hematopoietic cells by BCR/ABL requires activation of a PI‐3k/Akt‐dependent pathway

  1997cited by this paper
• Overexpression of the Heme Oxygenase Gene in Renal Cell Carcinoma

  1997cited by this paper
• Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors.

  1996cited by this paper
• Tetracycline-reversible silencing of eukaryotic promoters

  1995cited by this paper
• Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.

  1994cited by this paper
• Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin

  1989cited by this paper
• Human heme oxygenase cDNA and induction of its mRNA by hemin.

  1988cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

  1982cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• A minute chromosome in human chronic granulocytic leukemia

  1960cited by this paper

• Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy.

  2025cites this paper
• Heme Oxygenase-1-Targeted Cancer Therapy: At the Crossroads of Cytoprotection and Tumour Progression

  2025cites this paper
• The neuroprotective role of CncC in a Drosophila model of Parkinson’s disease

  2025cites this paper
• Immunosuppression of HMOX1 contributes to metastasis and poor prognosis in glioma.

  2025cites this paper
• Targeting protein tyrosine phosphatase non-receptor type 6 (PTPN6) as a therapeutic strategy in acute myeloid leukemia

  2024cites this paper
• Metal ion interference therapy: metal-based nanomaterial-mediated mechanisms and strategies to boost intracellular "ion overload" for cancer treatment.

  2024cites this paper
• The prognostic and therapeutic potential of HO-1 in leukemia and MDS

  2023cites this paper
• The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells

  2023cites this paper
• Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy

  2023cites this paper
• The dual role of heme oxygenase in regulating apoptosis in the nervous system of Drosophila melanogaster

  2023cites this paper
• Excess Heme Promotes the Migration and Infiltration of Macrophages in Endometrial Hyperplasia Complicated with Abnormal Uterine Bleeding

  2022cites this paper
• Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia

  2022cites this paper
• The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects

  2021cites this paper
• Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas

  2021cites this paper
• Nanomessenger-Mediated Signaling Cascade for Antitumor Immunotherapy.

  2021cites this paper
• Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.

  2020cites this paper
• Chaperones and Beyond as Key Players in Pluripotency Maintenance

  2019cites this paper
• نقش سیستم هم اکسیژناژ بر روی رشد تومور ملانوما در موش های نژاد C57Bl6

  2019cites this paper
• HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies

  2019cites this paper
• Heme oxygenase‐1 reduces the sensitivity to imatinib through nonselective activation of histone deacetylases in chronic myeloid leukemia

  2018cites this paper
• A Dual Role of Heme Oxygenase-1 in Cancer Cells

  2018cites this paper
• Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.

  2018cites this paper
• Heme oxygenase inhibition in cancers: possible tools and targets

  2018cites this paper
• Association between (GT)n Repeats in Heme Oxygenase-1 Gene Promoter and 3-Year Survival of Patients with Acute Leukemia: a Controlled, Cross-Sectional Study

  2018cites this paper
• Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.

  2017cites this paper
• Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia

  2017cites this paper
• The Heme Oxygenase System in Hematological Malignancies

  2017influential citation
• Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

  2017cites this paper
• Medicine Open Access book

  2017cites this paper
• 15d-PGJ2 as an endoplasmic reticulum stress manipulator in multiple myeloma in vitro and in vivo.

  2017cites this paper
• Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.

  2016cites this paper
• Induction of Oxidative Stress by Hyperthermia and Enhancement of Hyperthermia-Induced Apoptosis by Oxidative Stress Modification

  2016cites this paper
• Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL

  2016cites this paper
• Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors

  2016cites this paper
• A New Insight into the Effect of Heme Oxygenase-1 in Progress of Malignant Tumors

  2016cites this paper
• Styrene-maleic acid-copolymer conjugated zinc protoporphyrin as a candidate drug for tumor-targeted therapy and imaging

  2016cites this paper
• Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus

  2016cites this paper
• Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters

  2016cites this paper
• DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections

  2016cites this paper
• Effect of different chemical bonds in pegylation of zinc protoporphyrin that affects drug release, intracellular uptake, and therapeutic effect in the tumor.

  2015cites this paper
• HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy.

  2015cites this paper
• Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma

  2015cites this paper
• In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells

  2015cites this paper
• Heme oxygenase-1: emerging target of cancer therapy

  2015cites this paper
• Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity

  2015cites this paper
• Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.

  2015cites this paper
• Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.

  2015cites this paper
• Induction of Heme Oxygenase-1 by Na+-H+ Exchanger 1 Protein Plays a Crucial Role in Imatinib-resistant Chronic Myeloid Leukemia Cells*

  2015cites this paper
• Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.

  2015cites this paper
• Imatinib inhibits the expression of SCO2 and FRATAXIN genes that encode mitochondrial proteins in human Bcr-Abl⁺ leukemia cells.

  2014cites this paper
• Potential crosstalk of Ca 2 +-ROS-dependent mechanism involved in apoptosis of Kasumi-1 cells mediated by heme oxygenase-1 small interfering RNA

  2014cites this paper
• Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

  2014cites this paper
• Potential crosstalk of Ca2+-ROS-dependent mechanism involved in apoptosis of Kasumi-1 cells mediated by heme oxygenase-1 small interfering RNA.

  2014cites this paper
• Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.

  2014cites this paper
• THE ROLE OF HEME OXYGENASE -1 SYSTEM IN MELANOMA TUMOR GROWTH OF C57BL/6 MICE

  2014cites this paper
• Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity

  2014cites this paper
• Role of Heme Oxygenase-1 in Postnatal Differentiation of Stem Cells: A Possible Cross-Talk with MicroRNAs

  2014cites this paper
• The effect of heme oxygenase-1 on breast cancer metastasis in vitro and in vivo

  2014cites this paper
• The expression, function and targeting of haem oxygenase-1 in cancer.

  2014cites this paper
• Dietary- and fasting-based interventions as novel approaches to improve the efficacy of cancer treatment

  2013cites this paper
• Overexpressions of HO-1/HO-1G143H in C57/B6J mice affect melanoma B16F10 lung metastases rather than change the survival rate of mice-bearing tumours

  2013cites this paper
• Oncogenic functions of the transcription factor Nrf2.

  2013cites this paper
• TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation

  2013cites this paper
• Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

  2013cites this paper
• A New Insight into the Effect of Heme Oxygenase-1 in Progress of Malignant Tumors

  2013cites this paper
• Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.

  2013cites this paper
• Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells.

  2013cites this paper
• Investigating the role of heme oxygenase and oxidative stress in oesophagogastric cancer

  2013cites this paper
• Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities

  2013cites this paper
• The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.

  2012cites this paper
• HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.

  2012cites this paper
• Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy?

  2012cites this paper
• Bortezomib induces heme oxygenase-1 expression in multiple myeloma

  2012cites this paper
• Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia

  2012cites this paper
• Identification of oncostatin M as a JAK2 V617F‐dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms

  2012cites this paper
• STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia

  2012cites this paper
• Pegylated Zinc Protoporphyrin: A Micelle-Forming Polymeric Drug for Cancer Therapy

  2012cites this paper
• Antioxidant Adaptive Response of Malignant Glioma Related to Resistance to Antitumor Treatment

  2012cites this paper
• Selective inhibition of hemeoxygenase-1 as a novel therapeutic target for anticancer treatment

  2011cites this paper
• Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles.

  2011cites this paper
• The Role of Nrf 2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells

  2011cites this paper
• Treatment of chronic myeloid leukemia when imatinib fails

  2011cites this paper
• Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept.

  2011cites this paper
• The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells

  2011cites this paper
• Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.

  2011cites this paper
• Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

  2010cites this paper
• Neoplastic stem cells: current concepts and clinical perspectives.

  2010cites this paper
• Heme oxygenase-1 in tumor biology and therapy.

  2010influential citation
• Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2.

  2010cites this paper
• Expression of heme oxygenase‐1 in human leukemic cells and its regulation by transcriptional repressor Bach1

  2010cites this paper
• Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion

  2010cites this paper
• NF-kappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction.

  2010cites this paper
• Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor

  2009cites this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cites this paper
• Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.

  2009influential citation
• Zinc Protoporphyrin Regulates Cyclin D1 Expression Independent of Heme Oxygenase Inhibition*

  2009cites this paper
• Therapeutic strategies by modulating oxygen stress in cancer and inflammation.

  2009cites this paper
• Hemin counteracts the repression of Bcl-2 and NrF2 genes and the cell killing induced by imatinib in human Bcr-Abl(+) CML cells.

  2009cites this paper
• Induction of heat shock proteins for protection against oxidative stress.

  2009cites this paper
• The therapeutic benefits of heme oxygenase (HO‐1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas

  2009cites this paper